军事知识服务平台
药物临床试验信息作为现有技术对发明专利新颖性和创造性的影响探析
Exploring the Impact of Drug Clinical Trial Information as Prior Art on the Novelty and Inventive Step of Inventions
摘要 在医药领域的专利审查实践中,临床试验证据的使用日益增多,但对此类证据的公开程度、是否给出技术启示及是否具有合理成功预期的判断,目前仍存在一定差异,进而影响发明新颖性及创造性评价的准确性.文章结合多个复审无效案例,探讨使用临床试验证据评价发明新颖性和创造性的审查思路及各环节的考量因素,以期为相关案件的审查提供参考.
Abstract:
In patent examination within the pharmaceutical field,clinical trial evidence is increasingly being used.However,in practice,there remain divergences in judging the disclosure scope of such evidence,the existence of technical teaching and a reasonable expectation of success,which further affects the accurate assessment of novelty and inventive step of inventions.Drawing on multiple reexamination and invalidation cases,this article discusses the examination approaches and key considerations at each step when using clinical trial evidence to evaluate the novelty and inventive step,aiming to provide references for the examination of related cases.
刊 名 专利代理
年,卷(期): 2026, (3)
分类号: D923.42
机标分类号: G252.7 R969.4 G306
在线出版日期: 2026年10月10日